Where Does Cyclo Therapeutics Inc (CYTH) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Risen 18.71% This Week?

Cyclo Therapeutics Inc (CYTH) is near the middle in its industry group according to InvestorsObserver. CYTH gets an overall rating of 37. That means it scores higher than 37 percent of stocks. Cyclo Therapeutics Inc gets a 62 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 141 out of 148 industries.

CYTH has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on CYTH!

See Full CYTH Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cyclo Therapeutics Inc Stock Today?

Cyclo Therapeutics Inc (CYTH) stock has fallen -0.55% while the S&P 500 has risen 0.51% as of 10:56 AM on Monday, Aug 7. CYTH is lower by -$0.01 from the previous closing price of $1.85 on volume of 23,610 shares. Over the past year the S&P 500 has risen 8.72% while CYTH is lower by -17.49%. CYTH lost -$1.83 per share the over the last 12 months. Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.